ESRRA and renal cell carcinoma: Autophagy is reported to play a protective role in the survival of tumor cells under targeted therapy or chemotherapy [4, 6]; therefore, the role of the ERRα acetylation-mediated autophagy-lysosome pathway in the sunitinib sensitivity of RCC cells was evaluated.